Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat
Identifieur interne : 001478 ( Main/Exploration ); précédent : 001477; suivant : 001479Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat
Auteurs : Joanna Iczkiewicz [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Source :
- European Journal of Neuroscience [ 0953-816X ] ; 2005-04.
English descriptors
Abstract
Nigral cell death in Parkinson's disease is characterized by glial cell activation leading to inflammatory changes. Osteopontin (OPN) is a glycosylated phosphoprotein that is induced by inflammatory mediators and which we have previously shown to be present in the substantia nigra. However, the role of OPN in the nigral inflammation is not known. We now report on the effects of lipopolysaccharide (LPS)‐induced glial cell activation in the substantia nigra of rats on OPN expression. LPS administration induced dopaminergic cell death as shown by reduced nigral tyrosine hydroxylase immunoreactivity. There was a corresponding time‐dependent increase in both OPN mRNA, which was maximal at 48 h, and protein levels, which peaked at 72 h before returning to control levels by 120 h. This increase was accompanied by marked reactive gliosis as shown by increased OX‐42, glial fibrillary acidic protein (GFAP) and ED1 immunoreactivity. OX‐42‐positive cells increased in a time‐dependent manner, peaking at 72 h before returning to control levels at 120 h. Similarly, ED1‐positive cells were present in their greatest numbers at 24 h but then gradually declined. These changes mirrored the alterations occurring in OPN protein and OPN mRNA, respectively. In contrast, GFAP‐positive cells only started to increase in number at 120 h. Colocalization studies showed that OPN was present in both ED1‐ and OX‐42‐positive cells but not in GFAP‐positive cells. These data confirm that intranigral injection of LPS induces a rapid and marked gliosis that accompanies the loss of tyrosine hydroxylase‐positive neurones and suggest that, after glial cell activation, enhanced expression of OPN occurs linked to increased numbers of microglia and/or macrophages. This suggests that OPN may be functionally important in the control of inflammatory changes.
Url:
DOI: 10.1111/j.1460-9568.2005.04009.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat</title><author><name sortKey="Iczkiewicz, Joanna" sort="Iczkiewicz, Joanna" uniqKey="Iczkiewicz J" first="Joanna" last="Iczkiewicz">Joanna Iczkiewicz</name></author><author><name sortKey="Rose, Sarah" sort="Rose, Sarah" uniqKey="Rose S" first="Sarah" last="Rose">Sarah Rose</name></author><author><name sortKey="Jenner, Peter" sort="Jenner, Peter" uniqKey="Jenner P" first="Peter" last="Jenner">Peter Jenner</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4D4398048703449D40240D0508E0D66E7D865610</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1111/j.1460-9568.2005.04009.x</idno><idno type="url">https://api.istex.fr/document/4D4398048703449D40240D0508E0D66E7D865610/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002174</idno><idno type="wicri:Area/Main/Curation">001E65</idno><idno type="wicri:Area/Main/Exploration">001478</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat</title><author><name sortKey="Iczkiewicz, Joanna" sort="Iczkiewicz, Joanna" uniqKey="Iczkiewicz J" first="Joanna" last="Iczkiewicz">Joanna Iczkiewicz</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Neurodegenerative Diseases Research Centre, Guy's, King's and St Thomas School of Biomedical Sciences, King's College, London SE1 1UL</wicri:regionArea><wicri:noRegion>London SE1 1UL</wicri:noRegion></affiliation></author><author><name sortKey="Rose, Sarah" sort="Rose, Sarah" uniqKey="Rose S" first="Sarah" last="Rose">Sarah Rose</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Neurodegenerative Diseases Research Centre, Guy's, King's and St Thomas School of Biomedical Sciences, King's College, London SE1 1UL</wicri:regionArea><wicri:noRegion>London SE1 1UL</wicri:noRegion></affiliation></author><author><name sortKey="Jenner, Peter" sort="Jenner, Peter" uniqKey="Jenner P" first="Peter" last="Jenner">Peter Jenner</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Neurodegenerative Diseases Research Centre, Guy's, King's and St Thomas School of Biomedical Sciences, King's College, London SE1 1UL</wicri:regionArea><wicri:noRegion>London SE1 1UL</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Neuroscience</title><idno type="ISSN">0953-816X</idno><idno type="eISSN">1460-9568</idno><imprint><publisher>Blackwell Science Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2005-04">2005-04</date><biblScope unit="volume">21</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="1911">1911</biblScope><biblScope unit="page" to="1920">1920</biblScope></imprint><idno type="ISSN">0953-816X</idno></series><idno type="istex">4D4398048703449D40240D0508E0D66E7D865610</idno><idno type="DOI">10.1111/j.1460-9568.2005.04009.x</idno><idno type="ArticleID">EJN4009</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0953-816X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>glial cells</term><term>inflammation</term><term>osteopontin</term><term>substantia nigra</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Nigral cell death in Parkinson's disease is characterized by glial cell activation leading to inflammatory changes. Osteopontin (OPN) is a glycosylated phosphoprotein that is induced by inflammatory mediators and which we have previously shown to be present in the substantia nigra. However, the role of OPN in the nigral inflammation is not known. We now report on the effects of lipopolysaccharide (LPS)‐induced glial cell activation in the substantia nigra of rats on OPN expression. LPS administration induced dopaminergic cell death as shown by reduced nigral tyrosine hydroxylase immunoreactivity. There was a corresponding time‐dependent increase in both OPN mRNA, which was maximal at 48 h, and protein levels, which peaked at 72 h before returning to control levels by 120 h. This increase was accompanied by marked reactive gliosis as shown by increased OX‐42, glial fibrillary acidic protein (GFAP) and ED1 immunoreactivity. OX‐42‐positive cells increased in a time‐dependent manner, peaking at 72 h before returning to control levels at 120 h. Similarly, ED1‐positive cells were present in their greatest numbers at 24 h but then gradually declined. These changes mirrored the alterations occurring in OPN protein and OPN mRNA, respectively. In contrast, GFAP‐positive cells only started to increase in number at 120 h. Colocalization studies showed that OPN was present in both ED1‐ and OX‐42‐positive cells but not in GFAP‐positive cells. These data confirm that intranigral injection of LPS induces a rapid and marked gliosis that accompanies the loss of tyrosine hydroxylase‐positive neurones and suggest that, after glial cell activation, enhanced expression of OPN occurs linked to increased numbers of microglia and/or macrophages. This suggests that OPN may be functionally important in the control of inflammatory changes.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Iczkiewicz, Joanna" sort="Iczkiewicz, Joanna" uniqKey="Iczkiewicz J" first="Joanna" last="Iczkiewicz">Joanna Iczkiewicz</name></noRegion><name sortKey="Jenner, Peter" sort="Jenner, Peter" uniqKey="Jenner P" first="Peter" last="Jenner">Peter Jenner</name><name sortKey="Rose, Sarah" sort="Rose, Sarah" uniqKey="Rose S" first="Sarah" last="Rose">Sarah Rose</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001478 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001478 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:4D4398048703449D40240D0508E0D66E7D865610
|texte= Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat
}}
| This area was generated with Dilib version V0.6.23. |  |